Feasibility and value of two-dimensional volumetric stress echocardiography.


Journal

Minerva cardiology and angiology
ISSN: 2724-5772
Titre abrégé: Minerva Cardiol Angiol
Pays: Italy
ID NLM: 101776555

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 14 7 2020
medline: 14 4 2022
entrez: 14 7 2020
Statut: ppublish

Résumé

Stroke volume response during stress is a major determinant of functional status in heart failure and can be measured by two-dimensional (2-D) volumetric stress echocardiography (SE). The present study hypothesis is that SE may identify mechanisms underlying the change in stroke volume by measuring preload reserve through end-diastolic volume (EDV) and left ventricular contractile reserve (LVCR) with systolic blood pressure and end-systolic volume (ESV). We enrolled 4735 patients (age 63.6±11.3 years, 2800 male) referred to SE for known or suspected coronary artery disease (CAD) and/or heart failure (HF) in 21 SE laboratories in 8 countries. In addition to regional wall motion abnormalities (RWMA), force was measured at rest and peak stress as the ratio of systolic blood pressure by cuff sphygmomanometer/ESV by 2D with Simpson's or linear method. Abnormal values of LVCR (peak/rest) based on force were ≤1.10 for dipyridamole (N.=1992 patients) and adenosine (N.=18); ≤2.0 for exercise (N.=2087) or dobutamine (N.=638). Force-based LVCR was obtained in all 4735 patients. Lack of stroke volume increase during stress was due to either abnormal LVCR and/or blunted preload reserve, and 57% of patients with abnormal LVCR nevertheless showed increase in stroke volume. Volumetric SE is highly feasible with all stresses, and more frequently impaired in presence of ischemic RWMA, absence of viability and reduced coronary flow velocity reserve. It identifies an altered stroke volume response due to reduced preload and/or contractile reserve.

Sections du résumé

BACKGROUND
Stroke volume response during stress is a major determinant of functional status in heart failure and can be measured by two-dimensional (2-D) volumetric stress echocardiography (SE). The present study hypothesis is that SE may identify mechanisms underlying the change in stroke volume by measuring preload reserve through end-diastolic volume (EDV) and left ventricular contractile reserve (LVCR) with systolic blood pressure and end-systolic volume (ESV).
METHODS
We enrolled 4735 patients (age 63.6±11.3 years, 2800 male) referred to SE for known or suspected coronary artery disease (CAD) and/or heart failure (HF) in 21 SE laboratories in 8 countries. In addition to regional wall motion abnormalities (RWMA), force was measured at rest and peak stress as the ratio of systolic blood pressure by cuff sphygmomanometer/ESV by 2D with Simpson's or linear method. Abnormal values of LVCR (peak/rest) based on force were ≤1.10 for dipyridamole (N.=1992 patients) and adenosine (N.=18); ≤2.0 for exercise (N.=2087) or dobutamine (N.=638).
RESULTS
Force-based LVCR was obtained in all 4735 patients. Lack of stroke volume increase during stress was due to either abnormal LVCR and/or blunted preload reserve, and 57% of patients with abnormal LVCR nevertheless showed increase in stroke volume.
CONCLUSIONS
Volumetric SE is highly feasible with all stresses, and more frequently impaired in presence of ischemic RWMA, absence of viability and reduced coronary flow velocity reserve. It identifies an altered stroke volume response due to reduced preload and/or contractile reserve.

Identifiants

pubmed: 32657562
pii: S0026-4725.20.05304-9
doi: 10.23736/S2724-5683.20.05304-9
doi:

Substances chimiques

Dobutamine 3S12J47372

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-159

Auteurs

Tonino Bombardini (T)

Faculty of Medicine, University of Banja-Luka, Clinical Center of The Republic of Srpska, Banja-Luka, Bosnia-Herzegovina.

Angela Zagatina (A)

Department of Cardiology, Saint Petersburg University Clinic, Saint Petersburg University, Russia.

Quirino Ciampi (Q)

Division of Cardiology, Fatebenefratelli Hospital, Benevento, Italy.

Lauro Cortigiani (L)

Department of Cardiology, San Luca Hospital, Lucca, Italy.

Antonello D'Andrea (A)

Department of Cardiology, Echocardiography Lab and Rehabilitation Unit, Monaldi Hospital, Second University of Naples, Naples, Italy.

Clarissa Borguezan Daros (C)

Division of Cardiology, Hospital Sao José, Criciuma, Brazil.

Nadezhda Zhuravskaya (N)

Department of Cardiology, Saint Petersburg University Clinic, Saint Petersburg University, Russia.

Jaroslaw D Kasprzak (JD)

Chair of Cardiology, Bieganski Hospital, Medical University, Lodz, Poland.

Karina Wierzbowska-Drabik (K)

Chair of Cardiology, Bieganski Hospital, Medical University, Lodz, Poland.

José L de Castro E Silva Pretto (JL)

Hospital Sao Vicente de Paulo e Hospital de Cidade, Passo Fundo, Brazil.

Ana Djordjevic-Dikic (A)

Cardiology Clinic, Clinical Center of Serbia, Medical School, University of Belgrade, Belgrade, Serbia.

Branko Beleslin (B)

Cardiology Clinic, Clinical Center of Serbia, Medical School, University of Belgrade, Belgrade, Serbia.

Marija Petrovic (M)

Cardiology Clinic, Clinical Center of Serbia, Medical School, University of Belgrade, Belgrade, Serbia.

Nikola Boskovic (N)

Cardiology Clinic, Clinical Center of Serbia, Medical School, University of Belgrade, Belgrade, Serbia.

Milorad Tesic (M)

Cardiology Clinic, Clinical Center of Serbia, Medical School, University of Belgrade, Belgrade, Serbia.

Ines P Monte (IP)

Echocardiography Lab, Department of Cardiothoracic and Vascular Medicine, A.O.U. Policlinic Rodolico, University of Catania, Catania, Italy.

Iana Simova (I)

Department of Cardiology, Acibadem City Clinic Cardiovascular Center, University Hospital, Sofia, Bulgaria.

Martina Vladova (M)

Department of Cardiology, Acibadem City Clinic Cardiovascular Center, University Hospital, Sofia, Bulgaria.

Alla Boshchenko (A)

Cardiology Research Institute, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia.

Tamara Ryabova (T)

Cardiology Research Institute, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russia.

Rodolfo Citro (R)

Echocardiography Lab, Department of Cardiology, San Giovanni di Dio e Ruggi d'Aragona University Hospital, Salerno, Italy.

Miguel Amor (M)

Ramos Mejia Hospital, Buenos Aires, Argentina.

Paul E Vargas Mieles (PE)

Ramos Mejia Hospital, Buenos Aires, Argentina.

Rosina Arbucci (R)

Service of Heart Diagnostics, Investigaciones Medicas, Buenos Aires, Argentina.

Claudio Dodi (C)

Casa di Cura Figlie di San Camillo, Cremona, Italy.

Fausto Rigo (F)

Department of Cardiology, Ospedale dell'Angelo, Mestre, Venice, Italy.

Suzana Gligorova (S)

Division of Cardiology, Casilino Hospital, Rome, Italy.

Milica Dekleva (M)

Zvezdara Clinical Center, Belgrade, Serbia.

Sergio Severino (S)

Coronary Care Unit, Department of Cardiology, Monaldi Hospital, Second University of Naples, Naples, Italy.

Marco A Torres (MA)

Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

Alessandro Salustri (A)

Department of Non-invasive Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.

Hugo Rodrìguez-Zanella (H)

Ignacio Chavez National Institute of Cardiology, Mexico City, Mexico.

Fabio M Costantino (FM)

Department of Cardiology, San Carlo Hospital, Potenza, Italy.

Albert Varga (A)

Institute of Family Medicine, University of Szeged, Szeged, Hungary.

Gergely Agoston (G)

Institute of Family Medicine, University of Szeged, Szeged, Hungary.

Eduardo Bossone (E)

AORN A. Cardarelli, Naples, Italy.

Francesco Ferrara (F)

AORN A. Cardarelli, Naples, Italy.

Nicola Gaibazzi (N)

Department of Cardiology, Parma University Hospital, Parma, Italy.

Granit Rabia (G)

Department of Cardiology, Parma University Hospital, Parma, Italy.

Jelena Celutkiene (J)

Center of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University Hospital, Vilnius, Lithuania.

Maciej Haberka (M)

Department of Cardiology, SHS, Medical University of Silesia, Katowice, Poland.

Fabio Mori (F)

Section of Cardiovascular Diagnostics, Department of Cardiothoracic and Vascular Medicine, Careggi University Hospital, Florence, Italy.

Maria G D'Alfonso (MG)

Section of Cardiovascular Diagnostics, Department of Cardiothoracic and Vascular Medicine, Careggi University Hospital, Florence, Italy.

Barbara Reisenhofer (B)

Division of Cardiology, Pontedera-Volterra Hospital, ASL Toscana3 Nord-Ovest, Pontedera, Pisa, Italy.

Ana C Camarozano (AC)

Hospital de Clinicas UFPR, Department of Medicine, Federal University of Paranà, Curitiba, Brazil.

Michael Salamé (M)

Ramos Mejia Hospital, Buenos Aires, Argentina.

Ewa Szymczyk (E)

Chair of Cardiology, Bieganski Hospital, Medical University, Lodz, Poland.

Paulina Wejner-Mik (P)

Chair of Cardiology, Bieganski Hospital, Medical University, Lodz, Poland.

Katarzyna Wdowiak-Okrojek (K)

Chair of Cardiology, Bieganski Hospital, Medical University, Lodz, Poland.

Tamara Kovacevic Preradovic (T)

Faculty of Medicine, University of Banja-Luka, Clinical Center of The Republic of Srpska, Banja-Luka, Bosnia-Herzegovina.

Fabio Lattanzi (F)

Department of Surgical, Medical, Molecular Pathology and Critical Area Medicine, Section of Cardiovascular Diseases, University of Pisa, Pisa, Italy.

Doralisa Morrone (D)

Department of Surgical, Medical, Molecular Pathology and Critical Area Medicine, Section of Cardiovascular Diseases, University of Pisa, Pisa, Italy.

Maria C Scali (MC)

Nottola-Montepulciano Hospital, Division of Cardiology, ASL Toscana Centro, Siena, Italy.

Miodrag Ostojic (M)

School of Medicine, Institute for Cardiovascular Disease Dedinje, Belgrade, Serbia.

Aleksandra Nikolic (A)

School of Medicine, Institute for Cardiovascular Disease Dedinje, Belgrade, Serbia.

Federica Re (F)

San Camillo Hospital, Division of Cardiology, Rome, Italy.

Andrea Barbieri (A)

Division of Cardiology, Policlinico University Hospital, Modena, Italy.

Giovanni DI Salvo (G)

Division of Cardiology, Department of Pediatric Cardiology, Brompton Hospital, Imperial College of London, London, UK.

Paolo Colonna (P)

Cardiology Hospital, Policlinico University Hospital, Bari, Italy.

Michele DE Nes (M)

Department of Biomedicine, Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.

Marco Paterni (M)

Department of Biomedicine, Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.

Pablo M Merlo (PM)

Service of Heart Diagnostics, Investigaciones Medicas, Buenos Aires, Argentina.

Jorge Lowenstein (J)

Service of Heart Diagnostics, Investigaciones Medicas, Buenos Aires, Argentina.

Clara Carpeggiani (C)

Department of Biomedicine, Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.

Dario Gregori (D)

Biostatistics, Epidemiology and Public Health Unit, Padua University, Padua, Italy.

Eugenio Picano (E)

Department of Biomedicine, Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy - picano@ifc.cnr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH